Sijmen de Vries
CEO, Pharming Group N.V.
Sijmen de Vries is the Chief Executive Officer at Pharming Group N.V.
In the past, he fulfilled various senior business and commercial positions at Novartis Pharma, Novartis Ophthalmics and SmithKline Beecham. Furthermore, he was Chief Executive Officer at 4-Antobody in Switzerland. Sijmen de Vries has a degree in Medicine from the Universiteit van Amsterdam.
Pharming is a speciality pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. It is committed to transforming the future for its patients. Pharming’s lead product, RUCONEST® treats acute hereditary angioedema (“HAE”) attacks in patients in Europe, the US, Israel and South Korea.